Complementary Roles for Receptor Clustering and Conformational Change in the Adhesive and Signaling Functions of Integrin αIIbβ3

Integrin αIIbβ3 mediates platelet aggregation and “outside-in” signaling. It is regulated by changes in receptor conformation and affinity and/or by lateral diffusion and receptor clustering. To document the relative contributions of conformation and clustering to αIIbβ3 function, αIIb was fused at its cytoplasmic tail to one or two FKBP12 repeats (FKBP). These modified αIIb subunits were expressed with β3 in CHO cells, and the heterodimers could be clustered into morphologically detectable oligomers upon addition of AP1510, a membrane-permeable, bivalent FKBP ligand. Integrin clustering by AP1510 caused binding of fibrinogen and a multivalent (but not monovalent) fibrinogen-mimetic antibody. However, ligand binding due to clustering was only 25–50% of that observed when αIIbβ3 affinity was increased by an activating antibody or an activating mutation. The effects of integrin clustering and affinity modulation were additive, and clustering promoted irreversible ligand binding. Clustering of αIIbβ3 also promoted cell adhesion to fibrinogen or von Willebrand factor, but not as effectively as affinity modulation. However, clustering was sufficient to trigger fibrinogen-independent tyrosine phosphorylation of pp72Syk and fibrinogen-dependent phosphorylation of pp125FAK, even in non-adherent cells. Thus, receptor clustering and affinity modulation play complementary roles in αIIbβ3 function. Affinity modulation is the predominant regulator of ligand binding and cell adhesion, but clustering increases these responses further and triggers protein tyrosine phosphorylation, even in the absence of affinity modulation. Both affinity modulation and clustering may be needed for optimal function of αIIbβ3 in platelets.

[1]  S. Wright,et al.  Aggregation of complement receptors on human neutrophils in the absence of ligand , 1987, The Journal of cell biology.

[2]  Ching-shih Chen,et al.  A Novel Integrin-activated Pathway Forms PKB/Akt- stimulatory Phosphatidylinositol 3,4-Bisphosphate via Phosphatidylinositol 3-Phosphate in Platelets* , 1998, The Journal of Biological Chemistry.

[3]  Kristiina Vuori,et al.  Integrin Activation by R-ras , 1996, Cell.

[4]  J. Hoxie,et al.  Anti-idiotypic antibodies against an antibody to the platelet glycoprotein (GP) IIb-IIIa complex mimic GP IIb-IIIa by recognizing fibrinogen. , 1992, The Journal of biological chemistry.

[5]  K. Burridge,et al.  Focal adhesions, contractility, and signaling. , 1996, Annual review of cell and developmental biology.

[6]  S. Grinstein,et al.  Calreticulin is essential for integrin-mediated calcium signalling and cell adhesion , 1997, Nature.

[7]  B. Coller Perspectives Series: Cell Adhesion in Vascular Biology Platelet Gpiib/iiia Antagonists: the First Anti-integrin Receptor Therapeutics , 2022 .

[8]  M. Shuman,et al.  The platelet fibrinogen receptor: an immunogold-surface replica study of agonist-induced ligand binding and receptor clustering , 1987, The Journal of cell biology.

[9]  Timothy A. Springer,et al.  The dynamic regulation of integrin adhesiveness , 1994, Current Biology.

[10]  B. Gumbiner,et al.  Lateral clustering of the adhesive ectodomain: a fundamental determinant of cadherin function , 1997, Current Biology.

[11]  M. Bretscher,et al.  Circulating integrins: alpha 5 beta 1, alpha 6 beta 4 and Mac‐1, but not alpha 3 beta 1, alpha 4 beta 1 or LFA‐1. , 1992, The EMBO journal.

[12]  J. Rosa,et al.  Ser-752-->Pro mutation in the cytoplasmic domain of integrin beta 3 subunit and defective activation of platelet integrin alpha IIb beta 3 (glycoprotein IIb-IIIa) in a variant of Glanzmann thrombasthenia. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[13]  J. Fox,et al.  The Platelet Cytoskeleton Stabilizes the Interaction between and Its Ligand and Induces Selective Movements of Ligand-occupied Integrin (*) , 1996, The Journal of Biological Chemistry.

[14]  A. Hall,et al.  The assembly of integrin adhesion complexes requires both extracellular matrix and intracellular rho/rac GTPases , 1995, The Journal of cell biology.

[15]  C. C. Reynolds,et al.  On the role of the platelet membrane skeleton in mediating signal transduction. Association of GP IIb-IIIa, pp60c-src, pp62c-yes, and the p21ras GTPase-activating protein with the membrane skeleton. , 1993, The Journal of biological chemistry.

[16]  S. Schreiber,et al.  Functional analysis of Fas signaling in vivo using synthetic inducers of dimerization , 1996, Current Biology.

[17]  J. Brugge,et al.  Tyrosine phosphorylation and cytoskeletal reorganization in platelets are triggered by interaction of integrin receptors with their immobilized ligands. , 1993, The Journal of biological chemistry.

[18]  R. Montgomery,et al.  Platelets have more than one binding site for von Willebrand factor. , 1983, The Journal of clinical investigation.

[19]  J. Bennett The molecular biology of platelet membrane proteins. , 1990, Seminars in hematology.

[20]  P. Newman,et al.  Truncation of the cytoplasmic domain of beta3 in a variant form of Glanzmann thrombasthenia abrogates signaling through the integrin alpha(IIb)beta3 complex. , 1997, The Journal of clinical investigation.

[21]  J M Miller,et al.  Adhesion-activating phorbol ester increases the mobility of leukocyte integrin LFA-1 in cultured lymphocytes. , 1996, The Journal of clinical investigation.

[22]  J. Brugge,et al.  Integrins and signal transduction pathways: the road taken. , 1995, Science.

[23]  Shannon R. Magari,et al.  A humanized system for pharmacologic control of gene expression , 1996, Nature Medicine.

[24]  S. Shattil,et al.  RhoA and the function of platelet integrin alphaIIbbeta3. , 1998, Blood.

[25]  Brian Savage,et al.  Initiation of Platelet Adhesion by Arrest onto Fibrinogen or Translocation on von Willebrand Factor , 1996, Cell.

[26]  B. Savage,et al.  Modulation of platelet function through adhesion receptors. A dual role for glycoprotein IIb-IIIa (integrin alpha IIb beta 3) mediated by fibrinogen and glycoprotein Ib-von Willebrand factor. , 1992, The Journal of biological chemistry.

[27]  Kenneth M. Yamada,et al.  Molecular interactions in cell adhesion complexes. , 1997, Current opinion in cell biology.

[28]  P. Sims,et al.  Effect of platelet activation on the conformation of the plasma membrane glycoprotein IIb-IIIa complex. , 1991, The Journal of biological chemistry.

[29]  T. Clackson Controlling mammalian gene expression with small molecules. , 1997, Current opinion in chemical biology.

[30]  V. Quaranta,et al.  Integrin cytoplasmic domains mediate inside-out signal transduction , 1994, The Journal of cell biology.

[31]  S. Shattil,et al.  RhoA and the Function of Platelet Integrin a IIb b , 1998 .

[32]  R. Juliano Cooperation between soluble factors and integrin‐mediated cell anchorage in the control of cell growth and differentiation , 1996, BioEssays : news and reviews in molecular, cellular and developmental biology.

[33]  J. Hoxie,et al.  Changes in the platelet membrane glycoprotein IIb.IIIa complex during platelet activation. , 1985, The Journal of biological chemistry.

[34]  A. Hall,et al.  Rho GTPases and the actin cytoskeleton. , 1998, Science.

[35]  M. Schwartz,et al.  Affinity Modulation of Platelet Integrin αIIbβ3 by β3-Endonexin, a Selective Binding Partner of the β3 Integrin Cytoplasmic Tail , 1997, The Journal of cell biology.

[36]  R L Juliano,et al.  Signal transduction by integrins: increased protein tyrosine phosphorylation caused by clustering of beta 1 integrins. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[37]  J. White Self-association of bound fibrinogen on platelet surfaces. , 1997, The Journal of laboratory and clinical medicine.

[38]  D. Holt,et al.  A versatile synthetic dimerizer for the regulation of protein-protein interactions. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[39]  S. Schreiber,et al.  Small-molecule control of insulin and PDGF receptor signaling and the role of membrane attachment , 1998, Current Biology.

[40]  M. Schwartz,et al.  Integrin signaling: roles for the cytoplasmic tails of αIIbβ3 in the tyrosine phosphorylation of pp125 FAK , 1995 .

[41]  G. Vilaire,et al.  Effect of Cytoplasmic Domain Mutations on the Agonist-stimulated Ligand Binding Activity of the Platelet Integrin αIIbβ3* , 1996, The Journal of Biological Chemistry.

[42]  J. Rosa,et al.  A point mutation in the integrin beta 3 cytoplasmic domain (S752-->P) impairs bidirectional signaling through alpha IIb beta 3 (platelet glycoprotein IIb-IIIa). , 1994, Blood.

[43]  J H Hartwig,et al.  Mechanisms of actin rearrangements mediating platelet activation , 1992, The Journal of cell biology.

[44]  R. Liddington,et al.  Cell adhesion in vascular biology. New insights into integrin-ligand interaction. , 1997, The Journal of clinical investigation.

[45]  D. Phillips,et al.  Design of potent and specific integrin antagonists. Peptide antagonists with high specificity for glycoprotein IIb-IIIa. , 1993, The Journal of biological chemistry.

[46]  M. Schwartz,et al.  Integrins: emerging paradigms of signal transduction. , 1995, Annual review of cell and developmental biology.

[47]  T. O’Toole,et al.  Determinants of specificity of a baculovirus-expressed antibody Fab fragment that binds selectively to the activated form of integrin alpha IIb beta 3. , 1994, The Journal of biological chemistry.

[48]  S. Shattil,et al.  RhoA and the Function of Platelet Integrin αIIbβ3 , 1998 .

[49]  K. Yamada,et al.  Integrin function: molecular hierarchies of cytoskeletal and signaling molecules , 1995, The Journal of cell biology.

[50]  J. Ramos,et al.  Complementation of dominant suppression implicates CD98 in integrin activation , 1997, Nature.

[51]  A. Horwitz,et al.  Adhesion-growth factor interactions during differentiation: an integrated biological response. , 1996, Developmental biology.

[52]  J. Weisel,et al.  Long range propagation of conformational changes in integrin α(IIb)β3 , 1993 .

[53]  Bennett Js The molecular biology of platelet membrane proteins. , 1990 .

[54]  E. Peerschke Regulation of Platelet Aggregation by Post-fibrinogen Binding Events , 1995, Thrombosis and Haemostasis.

[55]  R. Liddington,et al.  New insights into integrin-ligand interaction. , 1997, The Journal of clinical investigation.

[56]  J. Hawiger,et al.  Evidence that changes in platelet cyclic AMP levels regulate the fibrinogen receptor on human platelets. , 1982, The Journal of biological chemistry.

[57]  T. Pawson,et al.  Signaling through scaffold, anchoring, and adaptor proteins. , 1997, Science.

[58]  C. Figdor,et al.  Activation and inactivation of adhesion molecules. , 1993, Current topics in microbiology and immunology.

[59]  G. Bazzoni,et al.  Are changes in integrin affinity and conformation overemphasized? , 1998, Trends in biochemical sciences.

[60]  A. Horwitz,et al.  Integrin cytoplasmic domains: mediators of cytoskeletal linkages and extra- and intracellular initiated transmembrane signaling. , 1993, Current opinion in cell biology.

[61]  J. Weisel,et al.  Long range propagation of conformational changes in integrin alpha IIb beta 3. , 1993, The Journal of biological chemistry.

[62]  W. DeGrado,et al.  Agonist-activated αvβ3 on Platelets and Lymphocytes Binds to the Matrix Protein Osteopontin* , 1997, The Journal of Biological Chemistry.

[63]  C. Figdor,et al.  Extracellular Ca2+ modulates leukocyte function-associated antigen-1 cell surface distribution on T lymphocytes and consequently affects cell adhesion , 1994, The Journal of cell biology.

[64]  G. Burns,et al.  Capture by chemical crosslinkers provides evidence that integrin alpha IIb beta 3 forms a complex with protein tyrosine kinases in intact platelets. , 1995, The Biochemical journal.

[65]  J. Brugge,et al.  Regulation of the pp72syk protein tyrosine kinase by platelet integrin αIIbβ3 , 1997 .

[66]  E. Peerschke Bound fibrinogen distribution on stimulated platelets. Examination by confocal scanning laser microscopy. , 1995, The American journal of pathology.

[67]  M. Sheetz,et al.  Mutational Evidence for Control of Cell Adhesion Through Integrin Diffusion/Clustering, Independent of Ligand Binding , 1997, The Journal of experimental medicine.

[68]  B. Seed,et al.  αLβ2 Integrin/LFA-1 Binding to ICAM-1 Induced by Cytohesin-1, a Cytoplasmic Regulatory Molecule , 1996, Cell.

[69]  S. Shattil,et al.  Integrin signaling: the platelet paradigm. , 1998, Blood.

[70]  I. Charo,et al.  Design of potent and specific integrin antagonists. Peptide antagonists with high specificity for glycoprotein IIb-IIIa. , 1993, The Journal of biological chemistry.

[71]  M. Schwartz,et al.  Suppression of Integrin Activation: A Novel Function of a Ras/Raf-Initiated MAP Kinase Pathway , 1997, Cell.

[72]  J. Brugge,et al.  Regulation of the protein tyrosine kinase pp72syk by platelet agonists and the integrin alpha IIb beta 3. , 1994, The Journal of biological chemistry.

[73]  P. Sims,et al.  αIIbβ3 Redistribution Triggered by Receptor Cross-Linking , 1997 .

[74]  J. Brugge,et al.  Adhesive ligand binding to integrin alpha IIb beta 3 stimulates tyrosine phosphorylation of novel protein substrates before phosphorylation of pp125FAK , 1993, The Journal of cell biology.

[75]  J. Loscalzo,et al.  Nitric oxide released from activated platelets inhibits platelet recruitment. , 1997, The Journal of clinical investigation.

[76]  M. Schwartz,et al.  Integrin signaling: roles for the cytoplasmic tails of alpha IIb beta 3 in the tyrosine phosphorylation of pp125FAK. , 1995, Journal of cell science.